Bloomberg Television
Bloomberg Television
@markets·3.2M subscribers·95.6K videos

Hims Won't Back Down From Selling Cheap Weight-Loss Shots

Posted

June 26, 2025

Views

3,031

Likes

37

Comments

4

Engagement

1.35%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Hims & Hers Health CEO Andrew Dudum said the company will continue to sell cheap weight-loss shots despite Novo Nordisk A/S ending their distribution partnership over "deceptive marketing" practices. Sam Fazeli has more on "Bloomberg Open Interest."

--------

More on Bloomberg Television and Markets

Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance

Visit for business news & analysis, uptotheminute market data, features, profiles and more.

Connect with Bloomberg Television on:

Connect with Bloomberg Business on:

More from Bloomberg:

Bloomberg Radio

Bloomberg Surveillance

Bloomberg Politics

Bloomberg Originals

Watch more on YouTube:

Bloomberg Technology

Bloomberg Originals

Bloomberg Quicktake

Bloomberg Espanol

Bloomberg Podcasts

Guests & Subjects Covered

Novo Nordisk ASSam FazeliBloomberg Open InterestMarkets LikeBloomberg MarketsFinance VisitX Facebook Instagram ConnectBloomberg Business

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Hims Won't Back Down From Selling Cheap Weight-Loss Shots · Bloomberg Television · Sentinel